NCT01930162
- Conditions
- Acute Lymphocytic Leukemia, Blood Protein Disorders, Bone Marrow Diseases, +32 more
- Locations
-
- Novartis Investigative Site Minneapolis, Minnesota, United States
Clinical trial condition
Hemostatic Disorders
Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.
3,080 public trials
582 recruiting studies
Hemostatic Disorders trial results
NCT00424983
- Conditions
- Blood Protein Disorders, Breast Cancer, Breast Diseases, +18 more
- Locations
-
- Oncotherapeutics West Hollywood, California, United States
- Rocky Mountain Cancer Centers RMCC Greenwood Village, Colorado, United States
- Norwalk Hospital Norwalk, Connecticut, United States
- Hillman Cancer Center Pittsburgh, Pennsylvania, United States
NCT00532675
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- UCSF Medical Center San Francisco, California, United States
- Emory University School of Medicine/Winship Cancer Institute Dept. of Winship Cancer Inst. Atlanta, Georgia, United States
- St. Vincent's Comprehensive Cancer Center New York, United States
- Novartis Investigative Site South Brisbane, Queensland, Australia
NCT01058434
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- University of South Alabama / Mitchell Cancer Institute Dept. of Mitchell Cancer Inst. Mobile, Alabama, United States
- Central Hematology Oncology Medical Group Alhambra, California, United States
- Central Coast Medical Oncology Corporation Santa Maria, California, United States
- St. Jude Heritage Medical Group Virginia Crosson Cancer Center Yorba Linda, California, United States
NCT00532389
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Innovative Medical Research of South Florida Dept.ofInnovativeMedResearch Miami Shores, Florida, United States
- Dana Farber Cancer Institute Clinical Research Coordinator Boston, Massachusetts, United States
- Hackensack University Medical Center Multiple Myeloma Division Hackensack, New Jersey, United States
- Swedish Medical Center Dept.ofSwedishMedicalCtr. Seattle, Washington, United States
NCT02825212
- Conditions
- Blood Protein Disorders, Blood-Borne Infections, Cardiovascular Diseases, +22 more
- Locations
-
- Icahn School of Medicine at Mount Sinai New York, United States
NCT02144038
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- University of Texas/MD Anderson Cancer Center Dept.ofMDAndersonCancerCtr(SC) Houston, Texas, United States
- Seattle Cancer Care Alliance Oncology Dept Seattle, Washington, United States
- University of Wisconsin / Paul P. Carbone Comp Cancer Center Dept of Onc. Madison, Wisconsin, United States
- Novartis Investigative Site Prahran, Victoria, Australia
NCT02439112
- Conditions
- Behavior, Blood Protein Disorders, Bone Diseases, +20 more
- Locations
-
- Odense University Hospital Odense, Denmark
NCT01337752
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Female Urogenital Diseases, +19 more
- Locations
-
- University Chicago Hospital Dept. of Univ of Chicago (2) Chicago, Illinois, United States
- Medical Oncology Associates, PS Spokane, Washington, United States
- Novartis Investigative Site Valencia, Spain
- Novartis Investigative Site Madrid, Spain
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Mayo Clinic - Arizona Cancer Clinical Research Unit Scottsdale, Arizona, United States
- Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(3) San Antonio, Texas, United States
- Novartis Investigative Site Melbourne, Australia
- Novartis Investigative Site Frankfurt, Germany